Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 18;8(2):358-64.
doi: 10.3980/j.issn.2222-3959.2015.02.26. eCollection 2015.

Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy

Yan Gao  1 , Yan Zhang  2 , Yu-Sha Ru  2 , Xiao-Wu Wang  1 , Ji-Zhong Yang  1 , Chun-Hui Li  3 , Hong-Xing Wang  4 , Xiao-Rong Li  2 , Bing Li  1
Affiliations

Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy

Yan Gao et al. Int J Ophthalmol. .

Abstract

Aim: To detect and analyze the changes on ocular surface and tear function in type II diabetic patients with proliferative diabetic retinopathy (PDR), an advanced stage of diabetic retinopathy (DR), using conventional ophthalmic tests and the high-resolution laser scanning confocal microscopy.

Methods: Fifty-eight patients with type II diabetes were selected. Based on the diagnostic criteria and stage classification of DR, the patients were divided into the non-DR (NDR) group and the PDR group. Thirty-six patients with cataract but no other ocular and systemic disease were included as non-diabetic controls. All the patients were subjected to the conventional clinical tests of corneal sensitivity, Schirmer I Test, and corneal fluorescein staining. The non-invasive tear film break-up time (NIBUT) and tear interferometry were conducted by a Tearscope Plus. The morphology of corneal epithelia and nerve fibers was examined using the high-resolution confocal microscopy.

Results: The NDR group exhibited significantly declined corneal sensitivity and Schirmer I test value, as compared to the non-diabetic controls (P< 0.001). The PDR group showed significantly reduced corneal sensitivity, Schirmer I test value, and NIBUT in comparison to the non-diabetic controls (P < 0.001). Corneal fluorescein staining revealed the progressively injured corneal epithelia in the PDR patients. Moreover, significant decrease in the corneal epithelial density and morphological abnormalities in the corneal epithelia and nerve fibers were also observed in the PDR patients.

Conclusion: Ocular surface changes, including blunted corneal sensitivity, reduced tear secretion, tear film dysfunction, progressive loss of corneal epithelia and degeneration of nerve fibers, are common in type II diabetic patients, particularly in the diabetic patients with PDR. The corneal sensitivity, fluorescein staining scores, and the density of corneal epithelial cells and nerve fibers in the diabetic patients correlate with the duration of diabetes. Therefore, ocular surface of the patients with PDR should be examined regularly by conventional approaches and confocal microscopy to facilitate early diagnosis and treatment of keratopathy.

Keywords: confocal microscopy; corneal sensitivity; ocular surface; proliferative diabetic retinopathy; tear film break-up time; type II diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Corneal sensitivity was measured by a Cochet-Bonnet esthesiometer
Corneal sensitivity was significantly reduced in both NDR and PDR group in comparison to the non-diabetic controls; corneal sensitivity in the PDR group was also significantly lower than that in the NDR group. bP< 0.001.
Figure 2
Figure 2. Basic tear secretion was measured by Schirmer I Test
Basic tear secretion in the NDR and PDR group was both significantly lower than that in the non-diabetic controls. The tear section in the PDR group was also significantly diminished as compared to that in the NDR group. dP< 0.001.
Figure 3
Figure 3. NIBUT was measured by a Tearscope Plus
The NIBUT in the PDR group was significantly shorter than that in the NDR group and the control group. The NIBUT in the NDR group was not significantly different from that in the controls. fP< 0.001.
Figure 4
Figure 4. Corneal epithelial cells were examined by a high-resolution confocal microscope
A: Corneal epithelia from the controls were in a regular shape and with a discerned contour; B: The irregular and swelled corneal epithelia were observed sporadically in the NDR group; C: Corneal epithelial exfoliation and edema were seen more frequently, and the epithelial cell edges were irregular and blurred in the patients with PDR; D: Scale bar = 25 µm. Density of corneal epithelial cells was measured by a HRT-II confocal microscope. The epithelial cell density in the PDR group was significantly lower than the controls and the NDR group. h P< 0.001.
Figure 5
Figure 5. Corneal nerve fibers were examined by confocal microscopy
A: In the control group, nerve fibers were straight and thick. The axonal fibers branched at acute angles; B: In the NDR group, nerve fibers were more tortuous and branched less than those in the control group; C: The nerve fibers in the PDR patients were sparse, thin and discontinued. The fibers had even fewer branches and exhibited more tortuous axonal trajectories than the NDR group. Scale bar = 25 µm; D: The density of corneal nerve fibers was examined by a HRT-II confocal microscope. The nerve fiber density in the PDR patients was significantly decreased as compared to that in the NDR and the control group. jP< 0.001.
See this image and copyright information in PMC

References

    1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40. - PubMed
    1. Smith-Palmer J, Brandle M, Trevisan R, Orsini Fedrici M, Liabat S, Valentine W. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(3):273–278. - PubMed
    1. Josifova T, Schneider U, Henrich PB, Schrader W. Eye disorders in diabetes: potential drug targets. Infect Disord Drug Targets. 2008;8(2):70–75. - PubMed
    1. Fong DS, Aiello LP, Ferris FR, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540–2553. - PubMed
    1. Inoue K, Kato S, Ohara C, Numaga J, Amano S, Oshika T. Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea. 2001;20(8):798–801. - PubMed

LinkOut - more resources